AdvocacyRSS2 days ago
A patient with MS shares their personal experience of why starting treatment quickly with the most powerful available medications is worth it to them. They believe the benefits of aggressive, early treatment outweigh the potential side effects. This is one patient's perspective on MS treatment strategy.
WHY IT MATTERSThis patient perspective highlights the real-world decision-making that people with MS face when choosing between starting strong treatments early versus waiting, which can help other newly diagnosed patients think through their own treatment conversations.
Clinical trialRSS2 days ago
Scientists are testing a new vaccine against Epstein-Barr virus (EBV), a common virus that may trigger multiple sclerosis (MS). Early research suggests that preventing EBV infection could help prevent or reduce MS development. This vaccine could be a major breakthrough for people at risk of developing MS or those already living with the disease.
WHY IT MATTERSIf successful, an EBV vaccine could prevent MS from developing in the first place, offering a potential cure-like approach rather than just managing symptoms after diagnosis.
NewsUNITERAREApr 3
The PAN Foundation's Multiple Sclerosis Fund, which helped patients pay for MS medications and treatments, is currently closed and not accepting new applications. The fund previously offered up to $12,000 per year in financial assistance. The status changed on April 2, 2026, so it may reopen in the future.
WHY IT MATTERSIf you have MS and were relying on this fund to help pay for your medications, you'll need to find alternative financial assistance programs immediately since this specific fund is no longer accepting applications.